Abstract:Brain stimulation (BStim) encompasses multiple modalities (e.g., deep brain stimulation, responsive neurostimulation) that utilize electrodes implanted in deep brain structures to treat neurological disorders. Currently, BStim is primarily used to treat movement disorders such as Parkinson's, though indications are expanding to include neuropsychiatric disorders like depression and schizophrenia. Traditional BStim systems are "open-loop" and deliver constant electrical stimulation based on manually-determined parameters. Advancements in BStim have enabled development of "closed-loop" systems that analyze neural biomarkers (e.g., local field potentials in the sub-thalamic nucleus) and adjust electrical modulation in a dynamic, patient-specific, and energy efficient manner. These closed-loop systems enable real-time, context-specific stimulation adjustment to reduce symptom burden. Machine learning (ML) has emerged as a vital component in designing these closed-loop systems as ML models can predict / identify presence of disease symptoms based on neural activity and adaptively learn to modulate stimulation. We queried the US National Library of Medicine PubMed database to understand the role of ML in developing closed-loop BStim systems to treat epilepsy, movement disorders, and neuropsychiatric disorders. Both neural and non-neural network ML algorithms have successfully been leveraged to create closed-loop systems that perform comparably to open-loop systems. For disorders in which the underlying neural pathophysiology is relatively well understood (e.g., Parkinson's, essential tremor), most work has involved refining ML models that can classify neural signals as aberrant or normal. The same is seen for epilepsy, where most current research has focused on identifying optimal ML model design and integrating closed-loop systems into existing devices. For neuropsychiatric disorders, where the underlying pathologic neural circuitry is still being investigated, research is focused on identifying biomarkers (e.g., local field potentials from brain nuclei) that ML models can use to identify onset of symptoms and stratify severity of disease.

Progress in technology and clinical application of closed-loop brain neurostimulation

Physiologically informed neuromodulation

[Therapeutic applications of closed-loop brain stimulation. Success and expectations]

On closed-loop brain stimulation systems for improving the quality of life of patients with neurological disorders

Closed loop deep brain stimulation: an evolving technology

Closed-loop interaction with the cerebral cortex: a review of wireless implant technology

Landscape and future directions of machine learning applications in closed-loop brain stimulation

Wireless closed-loop deep brain stimulation using microelectrode array probes

Closed-loop neurostimulation in real-time for the treatment of pathological brain rhythms

Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders

Design of a novel closed-loop neural electrical stimulation system

Closed-Loop Adaptive Deep Brain Stimulation in Parkinson’s Disease: Procedures to Achieve It and Future Perspectives

[Advances in Application of Deep Brain Stimulation in Treatment of Neuropsychological Diseases].

Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders

Multimodal Technologies for Closed-Loop Neural Modulation and Sensing.

Review of Noninvasive or Minimally Invasive Deep Brain Stimulation

Deep Brain Stimulation Programming 2.0: Future Perspectives for Target Identification and Adaptive Closed Loop Stimulation

Brain-Machine Interfaces for Closed-Loop Electrical Brain Stimulation in Neuropsychiatric Disorders

Advances in The Development of New Stimulation Paradigms of Deep Brain Stimulation

Technology of deep brain stimulation: current status and future directions

Deep Brain Stimulation Initiative: Toward Innovative Technology, New Disease Indications, And Approaches To Current And Future Clinical Challenges In Neuromodulation Therapy